Essential tremor

Last updated

Essential tremor
Other namesIdiopathic tremor
Spiral drawing of Essential Tremor patient.svg
Archimedean spiral drawings by a man with a unilateral essential tremor. The spiral on the left was drawn by the subject using the left hand, and the one on the right using the right hand.
Specialty Neurology
Usual onsetAny age, but typically after 40
CausesUnknown
Risk factors Family history, exposure to particular toxins [1]
Diagnostic method Based on symptoms [2]
Differential diagnosis Cerebellar tremor, dystonic tremor, multiple sclerosis, Parkinson's disease [3]
TreatmentMedications, surgery [4]
Medication Beta blockers, primidone, anti-epileptics, topiramate, gabapentin, levetiracetam, benzodiazepines [4]
FrequencyAnnual incidence of 23.7 per 100,000 (2010) [5]

Essential tremor (ET), also called benign tremor, familial tremor, and idiopathic tremor, is a medical condition characterized by involuntary rhythmic contractions and relaxations (oscillations or twitching movements) of certain muscle groups in one or more body parts of unknown cause. [6] It is typically symmetrical, and affects the arms, hands, or fingers; but sometimes involves the head, vocal cords, or other body parts. [4] Essential tremor is either an action (intention) tremor—it intensifies when one tries to use the affected muscles during voluntary movements such as eating and writing—or it is a postural tremor, which occurs when holding arms outstretched and against gravity. This means that it is distinct from a resting tremor, such as that caused by Parkinson's disease, which is not correlated with movement. [7] Unlike Parkinson's disease, essential tremor may worsen with action.

Contents

Essential tremor is a progressive [8] [9] [10] neurological disorder, and the most common movement disorder. Though not life-threatening, it can certainly be debilitating. Its onset is usually between 40 and 50 years of age, but it can occur at any age. [11] The cause is poorly understood. Diagnosis is made by observing the typical pattern of the tremor coupled with the exclusion of known causes of such a tremor. There is currently no medical test available to identify an essential tremor.

While essential tremor is distinct from Parkinson's disease, which causes a resting tremor, essential tremor is nevertheless sometimes misdiagnosed as Parkinson's disease. [4] Some patients have been found to have both essential tremors and resting tremors. [4]

Treatments for essential tremor include medications, typically given sequentially to determine which provides the most efficacy with least side effects. Clostridium botulinum toxin (Botox) injections and ultrasound are also sometimes used for cases refractory to medications.

Signs and symptoms

The tremors linked with essential tremor are generally action tremors, which means they occur during intentional movements rather than when the body is at rest. [12]

In mild cases, ET can manifest as the inability to stop the tongue or hands from shaking, the ability to sing only in vibrato, and difficulty doing small, precise tasks such as threading a needle. Even simple tasks such as cutting in a straight line or using a ruler can range from difficult to impossible, depending on the severity of the condition. In disabling cases, ET can interfere with a person's activities of daily living, including feeding, dressing, and taking care of personal hygiene. Essential tremor generally presents as a rhythmic tremor (4–12 Hz) that occurs only when the affected muscle is exerting effort. Any sort of physical or mental stress tends to make the tremor worse. [2]

The tremor may also occur in the head (neck), jaw, and voice, as well as other body regions, with the general pattern being that the tremor begins in the arms and then spreads to these other regions in some people. Women are more likely to develop the head tremor than are men and it's also found to be more severe in women than men. [13] [14] In people with essential tremor (ET), the head tremor can be either vertical ("yes-yes") or horizontal ("no-no") and is typically accompanied by tremors in the hands or voice. [15] Other types of tremor may also occur, including postural tremor of the outstretched arms, intention tremor of the arms, and rest tremor in the arms. [16] In one study, men had more severe postural hand tremor when compared to women. [14] Some people may have unsteadiness and problems with gait and balance. [17] Abnormal tandem gait was more commonly observed in older ET people and those with more than 5 years of disease duration. [18]

ET-related tremors do not occur during sleep, but people with ET sometimes complain of an especially coarse tremor upon awakening that becomes noticeably less coarse within the first few minutes of wakefulness. Tremor and disease activity can intensify in response to fatigue, strong emotions, low blood sugar, extreme cold and heat, caffeine, lithium salts, some antidepressants, stress, and other factors. [19]

Parkinson's disease and parkinsonism can also occur simultaneously with ET. [4] The degree of tremor, rigidity, and functional disability did not differ from patients with idiopathic Parkinson's disease. Hand tremor predominated (as it did in Parkinson's disease), and occurred in nearly all cases, followed by head tremor, voice tremor, neck, face, leg, tongue, and trunk tremor. Most other tremors occurred in association with hand tremor. More severe tremors, a lower sleep disorder frequency, and a similar prevalence of other non-motor symptoms also can occur. [20] A non-motor feature such as hearing impairment has been shown to have higher prevalence in those with ET compared with those that are healthy or with Parkinson's. Cochlear pathologies which affects the inner ear are proposed as the potential cause, but there is still insufficient information regarding retrocochlear pathologies (affects central or neural nerve) and central auditory processing. [21]

Walking difficulties in essential tremor are common. About half of patients have associated dystonia, including cervical dystonia, writer's cramp, spasmodic dysphonia, and cranial dystonia, and 20% of the patients had associated parkinsonism. Olfactory dysfunction (loss of sense of smell) is common in Parkinson's disease, and has also been reported to occur in patients with essential tremor. A number of patients with essential tremor also exhibit many of the same neuropsychiatric disturbances seen in idiopathic Parkinson's disease. [22] The similarity in characteristics between parkinsonism and essential tremor can make it difficult to distinguish between the two at times. [4]

Essential tremor with tremor onset after the age of 65 has been associated with mild cognitive impairment, [23] as well as dementia, although the link between these conditions, if any, is still not understood. [24] [25] Familial cases of ET tend to present at younger ages, whereas older ages of onset are linked to faster progression of the disease. [26]

Essential tremor has two tremor components, central and peripheral. These two tremor components were identified by measuring the tremor of ET patients once with no weights on their hands and then with 1-pound weights on their hands. The addition of the weights resulted in a tremor spectrum with two peaks, one that maintained the same frequency (the central tremor) and one that decreased in frequency (the peripheral tremor). Only with the addition of the weights was the peripheral tremor distinguishable from the central tremor. [27]

The frequency of essential tremor is 4 to 12 Hz, depending on which body segment is affected. [28] Previously, it was 4 to 11 Hz according to the American Family Physician on Classification of Tremors and Treatment Update. [29] Proximal segments are affected at lower frequencies, and distal segments are affected at higher frequencies. [30]

Cause

Essential Tremor was once thought to be a single disease state, however, research shows that there are multiple factors that are associated with causing Essential Tremor. This leads to the consideration that Essential Tremor is more akin to a family of diseases, due to the presence of both genetic (familial) and sporadic Essential Tremors. [31] Currently, there are multiple main hypotheses behind Essential Tremor, being the degeneration of the cerebellum, inheriting the tremor, ingestion of toxins, or the presence of Lewy Bodies in the brainstem. [32] However, post mortem studies showed that only a small number of patients had Lewy Bodies, and was more common for patients not to exhibit them. [33]

Cerebellar

It is unknown how the degeneration of the cerebellum leads to Essential Tremor, however, it is hypothesized that it may be due to the loss of Purkinje cells, as they release gamma-aminobutyric acid (GABA), which is an inhibitory neurotransmitter meant to control the firing of neurons in the cerebellum. In certain Essential Tremor clinical studies which augment the GABA pathway, only some participants exhibited a reduction of tremor. [34] [35] Some patients have responded to alcohol, claiming alcohol has reduced the tremor, however the reduction is only short term. [36] However, alcohol might only be beneficial for those with an impacted GABA pathway, and may not be benefit patients who developed the tremor via other pathways.

Genetic

The main underlying cause of essential tremor is not clear, but many cases seem to be familial. [37] About half of the cases are due to a genetic mutation and the pattern of inheritance is most consistent with autosomal dominant transmission, meaning patients with Essential Tremor have around a 50% chance to pass it on to their children. [38] There are multiple gene mutations and presentations on various chromosomes that lead to Essential Tremor. [39] These include genes present on chromosomes 1–3, 6, 11, and 16. Each presentation or mutation of different genes were associated with families from different regions. For example, presentation of a gene associated with Essential Tremor on chromosome 6 has been noted in North American families, while a Canadian family was noted with mutations in the fused in sarcoma/translated in liposarcoma (FUS/TLS) gene. [32] Other mutations in genes such as the HTRA Serine Peptidase 2 (HTRA2) and the teneurin transmembrane protein 4 (TENM4), have been observed in a Turkish family and the Spanish population respectively. [32] Recent post mortem studies have displayed alterations in the leucine-rich repeat and immunoglobulin-like domain-containing protein 1 ( LINGO1 ) gene [40] [41] and GABA receptors [42] in the cerebellum of people with essential tremor. HAPT1 mutations have also been linked to ET, as well as to Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. [43]

Poisons and toxins

Some environmental poisons, including toxins, are also under active investigation, as they may play a role in the disease's cause. [44] Heavy metal exposure, specifically lead, has been associated with causation of ET. [32] [45] Lead is a heavy metal that can cross the central nervous system's (CNS) main line of defense, the blood–brain barrier, even increasing its permeability, allowing other harmful substances to access the CNS. [46] This allows lead access to the CNS allowing it to disturb processes that utilize calcium, including synaptic activity, and causes intracellular disruption, both of which may lead to irreversible damage to the CNS. [47] [48] This would include cerebellar damage which could cause ET. There are other poisons that work in a similar manner to lead such as other heavy metals like mercury and aluminum, as well as toxic chemicals like certain pesticides and alcohol. In particular, excessive alcohol consumption can worsen essential tremor due to damage to the cerebellum. [49]

Pathophysiology

Essential tremor is one of the most prevalent and poorly-understood neurological disorders. [50] Clinical, physiological and imaging studies point to involvement of the cerebellum and/or cerebellothalamocortical circuits. [51] The traditional model for essential tremor, the olivary hypothesis, suggests that ET is caused by abnormal electrical activity in the inferior olivary nucleus. This activity makes neurons fire in a regular, synchronized way, which then disrupts signals to the cerebellum and leads to tremors. [52] However, recent studies, especially those examining brain tissue, propose a new hypothesis that ET may be a neurodegenerative disease focused in the cerebellum, differing from the old theory [53] . Changes in the cerebellum could also be mediated by alcoholic beverage consumption. Purkinje cells are especially susceptible to ethanol excitotoxicity. [54] Impairment of Purkinje synapses is a component of cerebellar degradation that could underlie essential tremor. [54] Some cases have Lewy bodies in the locus ceruleus. [55] [56] [57] ET cases that progress to Parkinson's disease are less likely to have had cerebellar problems. [58] Recent neuroimaging studies [59] have suggested that the efficiency of the overall brain functional network in ET is disrupted.

In 2012, the National Toxicology Program concluded that sufficient evidence exists of an association between blood lead exposure at levels >10 μg/dl and essential tremor in adults, and limited evidence at blood lead levels >5 μg/dl. [60]

Diagnosis

Usually, the diagnosis is established on clinical grounds. Although ET was long considered a single-symptom illness, recent studies have shown that some patients also experience other additional motor symptoms and non-motor features. [53] According to recent medical literature, besides isolated essential tremor, there are two additional classifications: 'ET plus' and 'ET-PD.' 'ET plus' is diagnosed when patients show cognitive impairments or other motor symptoms like ataxia, dystonia, or resting tremor. 'ET-PD' is used for those who meet the criteria for both ET and Parkinson's disease. [61] The clinical features of tremor in a patient include medical history (such as age of onset, family history, progression over time, and exposure to drugs or toxins), tremor characteristics (like which parts of the body are affected, when the tremor occurs, and its frequency), and any associated signs(such as signs of systemic illness, neurological signs, and soft signs). For some types of tremors, additional tests like recording tremor frequency, imaging for lesions, receptor imaging, and biomarkers in blood or tissue may help identify the cause. [62] Tremors can start at any age, from birth through advanced ages (senile tremor). [63] [64] Any voluntary muscle in the body may be affected, although the tremor is most commonly seen in the hands and arms and slightly less commonly in the neck (causing the person's head to shake), tongue, and legs. A resting tremor of the hands is sometimes present. [22] [65] Tremor occurring in the legs might be diagnosable as orthostatic tremor. Tremors in the lower limbs are quite rare in ET and are more likely to indicate Parkinson's disease. [66]

ET occurs within multiple neurological disorders besides Parkinson's disease. This includes migraine disorders, where co-occurrences between ET and migraines have been examined. [67]

Treatment

Treatment approaches

Currently, most treatments and therapies available for essential tremors are only treating symptoms since there is no cure available. Medical treatments for tremors are based on shared decisions between patients and their providers. The choices of treatments depended on tremor severity, affected body parts, and the impacts of tremor on the patient's physical, psychological, and quality of life. [36] People with mild tremors that do not interfere with daily activities and psychological well-being do not require pharmacological treatments. People with persistent tremors which impact daily functions and social interactions should be treated with the appropriate pharmacological therapies. [36]

Non-pharmacological Treatment

"Focused Ultrasound" is a treatment that was approved for coverage in the U.S. in about 2022 for those with Medicare ins.. Totally non-surgical. Treatment process is done with patient totally conscious and takes 2 to 3 hours.

The first approach in helping people to improve tremor symptoms is the discontinuation of triggering and exacerbating factors like medications including certain antidepressants, anti-epileptics, beta-agonists; or substances like caffeine. [68] In addition, getting adequate sleep and utilizing relaxation techniques can also help improve and reduce tremor symptoms in individuals who reported an increase in tremors following physical activities. [68]

Since tremors can affect different parts of the body (like limbs, head, chin/jaw, and vocal), [69] different non-pharmacological therapeutic techniques are available that can support patients with the management of tremors including occupational therapy, speech therapy, and psychotherapy. [68] Occupational therapy provides support to help people manage everyday tasks more easily through different approaches and interventions. [69] Speech therapy is helpful in people with vocal tremor to help manage and maintain the vocal changes associated with tremor symptoms. Psychological impacts like embarrassment and anxiety are also important concerns of many people with ET which can lead to social isolation and depression. Psychotherapy can be very beneficial and play a key role in helping people to improve the mental health of ET people. [69]

Alcohol

Alcohol had been known to help provide short-term relief of tremor symptoms in some people, however, the therapeutic effects of alcohol on ET had not been studied in many clinical trials. It has been proposed that alcohol can help reduce tremors through the agonism mechanism of the gamma-aminobutyric acid GABAergic. [70] Since GABA can decrease neural activity, it is believed that alcohol can increase the activity of GABA which then can reduce involuntary muscle movements or tremors. However, the duration of action of alcohol on ET is around 3–4 hours, alcohol also had been associated with the rebound of tremor, not to mention the risk of development of long-term alcohol consumption and abuse. [36] The use of alcohol as a possible treatment for ET is not recommended by healthcare providers.

Pharmacological Treatments

Currently, The available pharmacological therapy options for ET are Beta-adrenergic blockers, Anticonvulsants, Benzodiazepines/GABAergic agents, Calcium channel blockers, and Atypical neuroleptic agents. The two most effective medications which had been approved by the FDA as first line agents for the treatment of ET are propranolol and primidone.

Beta-adrenergic Blockers

Chemical structure of Propranolol, one of the most effective medication for treating ET. Propranolol.svg
Chemical structure of Propranolol, one of the most effective medication for treating ET.

When symptoms are sufficiently troublesome to warrant treatment, the first choice medication is propranolol, a non-selective beta-blocker, which has been shown effective in reducing tremor by 70% in 50% of patients in clinical studies. [71] Based on the guidelines from the American Academy of Neurology and the Italian Movement Disorders Association, propranolol is most effective in limb tremors, also there is little to no effect on head tremors. The recommended doses of propranolol range from 60 to 360 mg daily, and it is based on the patient's specific factors. [71] The commonly reported side effects of propranolol are bradycardia, bronchospasm, fatigue, and hypotension. [72] In patients that have contraindicated comorbidities to propranolol, other beta-blockers such as Atenolol, pindolol, Sotalol, and nadolol have shown some potential efficacy, but they are not very well studied and have limited evidence in their efficacy on the treatment of ET. [36]

Anticonvulsants

chemical structures of primidone and two metabolites, phenobarbital and phenylethylmalonamide Primidone metaboliti.PNG
chemical structures of primidone and two metabolites, phenobarbital and phenylethylmalonamide

Primidone is another first line agent recommended in the treatment of ET. Primidone is an anticonvulsant which metabolized into phenobarbital and phenylethymalnonamide. [36] This medication has shown the same beneficial effects in reducing tremors as propranolol and is recommended for use based on guidelines from the American Academy of Neurology and the MDS Task Force on Tremor. The initial dose of primidone is recommended at 25 mg per day and should be increased up to the maximum dose of 250 mg per day. This strategy was recommended to help avoid the possible side effects of nausea, vomiting, and excessive sedation of primidone. [68] Primidone is the preferred medication for the treatment of ET in the geriatric population compared to propranolol. In addition, Combination therapy of both Propranolol and Primidone is recommended for people who do not show benefits from either propranolol or primidone as monotherapy. [72]

Topiramate is an antiepileptic medication which had been studied to assess the efficacy and safety in the treatment of ET. [72] Overall, it is considered a second-line therapy alone or in combination with other medications when first-line treatments fail to show improvement or medication intolerance. Topiramate has been shown effective in reducing limb tremors at the maximum dose of 200 mg, however, there was a higher risk for the development of adverse effects including weight loss, anorexia, cognitive impairment, and kidney stones. [68]

Other second-line medications

Additional medications that have been reported to show efficacy in treating ET are gabapentin, benzodiazepines such as alprazolam, clonazepam, and zonisamide, and pregabalin. [36] However, most of the medications have limited evidence-based to support their clinical usage as treatments for ET. Some systematic reviews of medications for the treatment of ET have been conducted. A 2017 review of topiramate found limited data and low-quality evidence to support its efficacy and the occurrence of treatment-limiting adverse effects, [73] a 2017 review of zonisamide found insufficient information to assess efficacy and safety, [74] and a 2016 review of pregabalin determined the effects to be uncertain due to the low quality of evidence. [75]

Botulinum Toxin (BoNT)

Botulinum toxin is a neurotoxin produced by a gram-positive, rod-shaped bacteria called Clostridium botulinum. BoNT works by inhibiting acetylcholine release at the presynaptic terminal by inactivating the SNARE proteins, which interfere with muscle contraction. [76] BoNT type A injections have shown benefits in several clinical trials for the treatments of limb, voice, and head. However, the associated side effects included muscle weakness, stiffness reported within studies of limb tremors, and neck muscle pain, weakness, and dysphagia in clinical trials of head tremors. [72] Botulinum toxin type A has been found to be helpful in treating voice tremors. [77]

Additional procedures

Ultrasound

Frontal MRI four days after MRgFUS (MRI-guided high-intensity focused ultrasound): Left ventral intermediate nucleus (Vim) thalamotomy. 79-year-old man with essential tremor. MRI-guided HIFU, essential tremor, 10-14 135, pointed.png
Frontal MRI four days after MRgFUS (MRI-guided high-intensity focused ultrasound): Left ventral intermediate nucleus (Vim) thalamotomy. 79-year-old man with essential tremor.

Additionally, MRI-guided high-intensity focused ultrasound is a nonsurgical treatment option for people with essential tremor who are medication refractory. [78] [79] MRI-guided high-intensity focused ultrasound does not achieve healing, but can improve the quality of life by reducing the tremor manifestation. [79] [80] While its long-term effects are not yet established, the improvement in tremor score from baseline was durable at 1 year and 2 years following the treatment. [81] To date, reported adverse events and side effects have been mild to moderate. Possible adverse events include gait difficulties, balance disturbances, paresthesias, headache, skin burns with ulcerations, skin retraction, scars, and blood clots. [78] [79] [82] This procedure is contraindicated in pregnant women, persons who have non-MRI compatible implanted metallic devices, allergy to MR contrast agents, cerebrovascular disease, abnormal bleeding, hemorrhage and/or blood clotting disorders, advanced kidney disease or on dialysis, heart conditions, severe hypertension, and ethanol or substance abuse, among others. [79] The US Food and Drug Administration (FDA) approved Insightec's Exablate Neuro system to treat essential tremor in 2016. [79]

Deep Brain Stimulation (DBS)

Illustration of the placement of electrodes and stimulator of Deep Brain Stimulation surgical treatment. Adaptive Deep Brain Stimulation.png
Illustration of the placement of electrodes and stimulator of Deep Brain Stimulation surgical treatment.

Another invasive surgical treatment of essential tremor is deep brain stimulation (DBS). DBS is a surgical procedure that involves the placement of a permanent electrode with 4-8 contacts within the brain with connecting wires connected to a pulse stimulator implanted near the patient's collarbone. [68] In the treatment of tremor, the electrodes are placed in the ventral intermediate nucleus (Vim) of the thalamus.

The pulse stimulator delivers constant electrical pulses to the target area, which interfere with activity of the target area, which has been shown to improve tremor symptoms. [83] At one year following the surgical intervention with DBS, patients showed 66% improvement and 48% improvement at 10 years. [72] DBS is considering an effective surgical treatment of ET, but there are associated side effects and complications that have been reported with DBS in clinical trials, including imbalance or gait instability, dystonia, paresthesia, hemorrhage. [71]

Prognosis

Although essential tremor is often mild, people with severe tremor have difficulty performing many of their routine activities of daily living. [84] [85] ET is generally progressive in most cases (sometimes rapidly, sometimes very slowly), and can be disabling in severe cases. [86] [87] [88]

Epidemiology

Essential tremor (ET) is a common neurological disorder, affecting up to 5% of the global population, with approximately 24.91 million people affected worldwide in 2020. [89] The prevalence of ET increases significantly with age, particularly in individuals aged 60 and above. [89] It affects around 4% of people aged 40 and older, and the prevalence rises to 2.87% in those over 80, reaching up to 20% in individuals in their 90s and beyond. [90] ET is more common in males than females across all age groups. [89]

Family history plays a significant role in the development of ET, with around 50% of cases being hereditary and a 90% concordance rate in identical twins. [91] While the likelihood of developing ET increases with age, it can also occur in younger individuals, especially if there is a family history of the disorder. [91] ET is one of the most common types of tremor, aside from enhanced physiological tremor, and is among the most frequently observed movement disorders. [92]

Society and culture

Actress Katharine Hepburn (1907–2003) had an essential tremor, possibly inherited from her grandfather, [93] that caused her head—and sometimes her hands—to shake. [94] [95] [96] The tremor was noticeable by the time of her performance in the 1979 film The Corn Is Green , when critics mentioned the "palsy that kept her head trembling". [97] Hepburn's tremor worsened in her later life. [95]

Charles M. Schulz, American cartoonist and creator of the Peanuts comic strip, was affected during the last two decades of his life.

West Virginia Senator Robert Byrd also had essential tremor.

In 2010, musician Daryl Dragon of The Captain and Tennille was diagnosed with essential tremor, with the condition becoming so severe that Dragon was no longer able to play the keyboards. [98]

Director-writer-producer-comedian Adam McKay was diagnosed with essential tremor. [99]

Downton Abbey creator Julian Fellowes has the condition, as does the show's character Charlie Carson. [100]

In 2022, Matthew Caws of Nada Surf and his son made a PSA called "Living with a Mild Essential Tremor". [101]

Research

Harmaline is a widely used model of essential tremor (ET) in rodents. [102] Harmaline is thought to act primarily on neurons in the inferior olive. Olivocerebellar neurons exhibit rhythmic excitatory action when harmaline is applied locally. [102] Harmane or harmaline has been implicated not only in essential tremors, but is also found in greater quantities in the brain fluid of people with Parkinson's disease and cancer. [103] [104] [105] Higher levels of the neurotoxin are associated with greater severity of the tremors. [1] [106] Harmane is particularly abundant in meats, and certain cooking practices (e.g., long cooking times) increase its concentration, [107] [108] [109] but at least one study has shown that harmane blood concentrations do not go up after meat consumption in ET patients with already elevated harmane levels, whereas the control group's harmane levels increase accordingly, suggesting that another factor, such as a metabolic defect, may be responsible for the higher harmane levels in ET patients. [110]

Caprylic acid is being researched as a possible treatment for essential tremor. It has currently been approved by the FDA and designated as GRAS, and is used as a food additive and has been studied as part of a ketogenic diet for treatment of epilepsy in children. Research on caprylic acid as a possible treatment for ET began because researchers recognized that ethanol was effective in reducing tremor, and because of this, they looked into longer-chain alcohols reducing tremor. They discovered that 1-octanol reduced tremor and did not have the negative side effects of ethanol. Pharmacokinetic research on 1-octanol lead to the discovery that 1-octanol metabolized into caprylic acid in the body and that caprylic acid actually was the tremor-reducing agent. [111] Many studies of the effects of caprylic acid on essential tremor have been done, including a dose-escalation study on ET patients [112] and a study testing the effects of caprylic acid on central and peripheral tremor. [27] The dose-escalation study examined doses of 8 mg/kg to 128 mg/kg and determined that these concentrations were safe with mild side effects. The maximum tolerated dose was not reached in this study. The study testing the effects of caprylic acid on central and peripheral tremors determined that caprylic acid reduced both.

Terminology

This type of tremor is often referred to as "kinetic tremor". Essential tremor has been known as "benign essential tremor", but the adjective "benign" has been removed in recognition of the sometimes disabling nature of the disorder. [84] [85]

See also

Related Research Articles

Ataxia is a neurological sign consisting of lack of voluntary coordination of muscle movements that can include gait abnormality, speech changes, and abnormalities in eye movements, that indicates dysfunction of parts of the nervous system that coordinate movement, such as the cerebellum.

<span class="mw-page-title-main">Tremor</span> Involuntary muscle contraction

A tremor is an involuntary, somewhat rhythmic muscle contraction and relaxation involving oscillations or twitching movements of one or more body parts. It is the most common of all involuntary movements and can affect the hands, arms, eyes, face, head, vocal folds, trunk, and legs. Most tremors occur in the hands. In some people, a tremor is a symptom of another neurological disorder.

<span class="mw-page-title-main">Parkinsonism</span> Syndrome characterized by tremor, slowed movements, rigidity, and imbalance

Parkinsonism is a clinical syndrome characterized by tremor, bradykinesia, rigidity, and postural instability. Both hypokinetic as well as hyperkinetic features are displayed by Parkinsonism. These are the four motor symptoms found in Parkinson's disease (PD) – after which it is named – dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD), and many other conditions. This set of symptoms occurs in a wide range of conditions and may have many causes, including neurodegenerative conditions, drugs, toxins, metabolic diseases, and neurological conditions other than PD.

<span class="mw-page-title-main">Deep brain stimulation</span> Neurosurgical treatment

Deep brain stimulation (DBS) is a surgical procedure that implants a neurostimulator and electrodes which sends electrical impulses to specified targets in the brain responsible for movement control. The treatment is designed for a range of movement disorders such as Parkinson's disease, essential tremor, and dystonia, as well as for certain neuropsychiatric conditions like obsessive-compulsive disorder (OCD) and epilepsy. The exact mechanisms of DBS are complex and not entirely clear, but it is known to modify brain activity in a structured way.

<span class="mw-page-title-main">Dystonia</span> Neurological movement disorder

Dystonia is a neurological hyperkinetic movement disorder in which sustained or repetitive muscle contractions occur involuntarily, resulting in twisting and repetitive movements or abnormal fixed postures. The movements may resemble a tremor. Dystonia is often intensified or exacerbated by physical activity, and symptoms may progress into adjacent muscles.

<span class="mw-page-title-main">Multiple system atrophy</span> Neurodegenerative disorder

Multiple system atrophy (MSA) is a rare neurodegenerative disorder characterized by tremors, slow movement, muscle rigidity, postural instability, autonomic dysfunction and ataxia. This is caused by progressive degeneration of neurons in several parts of the brain including the basal ganglia, inferior olivary nucleus, and cerebellum.

<span class="mw-page-title-main">Nadolol</span> Non-selective beta blocker used in the treatment of high blood pressure and chest pain

Nadolol, sold under the brand name Corgard among others, is a medication used to treat high blood pressure, heart pain, atrial fibrillation, and some inherited arrhythmic syndromes. It has also been used to prevent migraine headaches and complications of cirrhosis. It is taken orally.

<span class="mw-page-title-main">Hyperkinesia</span> Excessive movements due to basal ganglia dysfunction

Hyperkinesia refers to an increase in muscular activity that can result in excessive abnormal movements, excessive normal movements, or a combination of both. Hyperkinesia is a state of excessive restlessness which is featured in a large variety of disorders that affect the ability to control motor movement, such as Huntington's disease. It is the opposite of hypokinesia, which refers to decreased bodily movement, as commonly manifested in Parkinson's disease.

<span class="mw-page-title-main">Progressive supranuclear palsy</span> Medical condition of the brain

Progressive supranuclear palsy (PSP) is a late-onset neurodegenerative disease involving the gradual deterioration and death of specific volumes of the brain. The condition leads to symptoms including loss of balance, slowing of movement, difficulty moving the eyes, and cognitive impairment. PSP may be mistaken for other types of neurodegeneration such as Parkinson's disease, frontotemporal dementia and Alzheimer's disease. The cause of the condition is uncertain, but involves the accumulation of tau protein within the brain. Medications such as levodopa and amantadine may be useful in some cases.

<span class="mw-page-title-main">Primidone</span> Barbiturate medication used to treat seizures and tremors

Primidone, sold under various brand names, is a barbiturate medication that is used to treat partial and generalized seizures and essential tremors. It is taken by mouth.

Blepharospasm is a neurological disorder characterized by intermittent, involuntary spasms and contractions of the orbicularis oculi (eyelid) muscles around both eyes. These result in abnormal twitching or blinking, and in the extreme, sustained eyelid closure resulting in functional blindness.

<span class="mw-page-title-main">Spasmodic torticollis</span> Medical condition

Spasmodic torticollis is an extremely painful chronic neurological movement disorder causing the neck to involuntarily turn to the left, right, upwards, and/or downwards. The condition is also referred to as "cervical dystonia". Both agonist and antagonist muscles contract simultaneously during dystonic movement. Causes of the disorder are predominantly idiopathic. A small number of patients develop the disorder as a result of another disorder or disease. Most patients first experience symptoms midlife. The most common treatment for spasmodic torticollis is the use of botulinum toxin type A.

Intention tremor is a dyskinetic disorder characterized by a broad, coarse, and low-frequency tremor evident during deliberate and visually-guided movement. An intention tremor is usually perpendicular to the direction of movement. When experiencing an intention tremor, one often overshoots or undershoots one's target, a condition known as dysmetria. Intention tremor is the result of dysfunction of the cerebellum, particularly on the same side as the tremor in the lateral zone, which controls visually guided movements. Depending on the location of cerebellar damage, these tremors can be either unilateral or bilateral.

In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief from the symptoms.

Ablative brain surgery is the surgical ablation by various methods of brain tissue to treat neurological or psychological disorders. The word "Ablation" stems from the Latin word Ablatus meaning "carried away". In most cases, however, ablative brain surgery does not involve removing brain tissue, but rather destroying tissue and leaving it in place. The lesions it causes are irreversible. There are some target nuclei for ablative surgery and deep brain stimulation. Those nuclei are the motor thalamus, the globus pallidus, and the subthalamic nucleus.

<span class="mw-page-title-main">Parkinson's disease</span> Long-term neurodegenerative disease

Parkinson's disease (PD), or simply Parkinson's, is a neurodegenerative disease of mainly the central nervous system that affects both the motor and non-motor systems of the body. The symptoms usually emerge slowly, and, as the disease progresses, non-motor symptoms become more common. Usual symptoms include tremors, slowness of movement, rigidity, and difficulty with balance, collectively known as parkinsonism. Parkinson's disease dementia, falls and neuropsychiatric problems such as sleep abnormalities, psychosis, mood swings, or behavioral changes may also arise in advanced stages.

<span class="mw-page-title-main">Signs and symptoms of Parkinson's disease</span> Signs and symptoms

Signs and symptoms of Parkinson's disease are varied. Parkinson's disease affects movement, producing motor symptoms. Non-motor symptoms, which include dysautonomia, cognitive and neurobehavioral problems, and sensory and sleep difficulties, are also common. When other diseases mimic Parkinson's disease, they are categorized as parkinsonism.

<span class="mw-page-title-main">Parkinsonian gait</span> Type of gait due to Parkinsons disease

Parkinsonian gait is the type of gait exhibited by patients with Parkinson's disease (PD). It is often described by people with Parkinson's as feeling like being stuck in place, when initiating a step or turning, and can increase the risk of falling. This disorder is caused by a deficiency of dopamine in the basal ganglia circuit leading to motor deficits. Gait is one of the most affected motor characteristics of this disorder although symptoms of Parkinson's disease are varied.

<span class="mw-page-title-main">History of Parkinson's disease</span>

The history of Parkinson's disease expands from 1817, when British apothecary James Parkinson published An Essay on the Shaking Palsy, to modern times. Before Parkinson's descriptions, others had already described features of the disease that would bear his name, while the 20th century greatly improved knowledge of the disease and its treatments. PD was then known as paralysis agitans. The term "Parkinson's disease" was coined in 1865 by William Sanders and later popularized by French neurologist Jean-Martin Charcot.

<span class="mw-page-title-main">Adaptive Deep Brain Stimulation</span> Neurosurgical treatment involving implantation of an adaptive neurostimularot

Adaptive Deep Brain Stimulation (aDBS), also known as Closed Loop Deep Brain stimulation (clDBS), is a neuro-modulatory technique currently under investigation for the treatment of neurodegenerative diseases.

References

  1. 1 2 Louis ED, Zheng W, Mao X, Shungu DC (August 2007). "Blood harmane is correlated with cerebellar metabolism in essential tremor: a pilot study". Neurology. 69 (6): 515–20. doi:10.1212/01.wnl.0000266663.27398.9f. PMID   17679670. S2CID   7612446.
  2. 1 2 "Essential Tremor Treatment at the Johns Hopkins Movement Disorders Center in Baltimore, MD". hopkinsmedicine.org. Retrieved October 27, 2014.
  3. ↑ Bhidayasiri R (December 2005). "Differential diagnosis of common tremor syndromes". Postgraduate Medical Journal. 81 (962): 756–62. doi:10.1136/pgmj.2005.032979. PMC   1743400 . PMID   16344298.
  4. 1 2 3 4 5 6 7 Abboud H, Ahmed A, Fernandez HH (December 2011). "Essential tremor: choosing the right management plan for your patient". Cleveland Clinic Journal of Medicine. 78 (12): 821–8. doi: 10.3949/ccjm.78a.10178 . PMID   22135272. S2CID   58374.
  5. ↑ Zesiewicz TA, Chari A, Jahan I, Miller AM, Sullivan KL (September 2010). "Overview of essential tremor". Neuropsychiatric Disease and Treatment. 6: 401–8. doi: 10.2147/ndt.s4795 . PMC   2938289 . PMID   20856604.
  6. ↑ "tremor" at Dorland's Medical Dictionary
  7. ↑ "LINGO1 variant responsible for essential tremors and Parkinson's disease". news-medical.net. 2009-09-02. Retrieved October 27, 2014.
  8. ↑ Shukla AW. "Essential Tremor Information". Unified Health. Retrieved 17 June 2018.
  9. ↑ Louis ED. "Essential Tremor". National Organization for Rare Disorders. Retrieved 17 June 2018.
  10. ↑ Gironell A, Ribosa-Nogué R, Gich I, Marin-Lahoz J, Pascual-Sedano B (2015). "Severity stages in essential tremor: a long-term retrospective study using the glass scale". Tremor and Other Hyperkinetic Movements . 5: 299. doi:10.7916/D8DV1HQC. PMC   4361372 . PMID   25793146.
  11. ↑ "Tremor". National Institute of Neurological Disorders and Stroke.
  12. ↑ Lenka A, Jankovic J (2021-07-26). "Tremor Syndromes: An Updated Review". Frontiers in Neurology. 12. doi: 10.3389/fneur.2021.684835 . ISSN   1664-2295. PMC   8350038 . PMID   34381412.
  13. ↑ Hardesty DE, Maraganore DM, Matsumoto JY, Louis ED (May 2004). "Increased risk of head tremor in women with essential tremor: longitudinal data from the Rochester Epidemiology Project". Movement Disorders. 19 (5): 529–533. doi:10.1002/mds.20096. PMID   15133816.
  14. 1 2 Hubble JP, Busenbark KL, Pahwa R, Lyons K, Koller WC (November 1997). "Clinical expression of essential tremor: effects of gender and age". Movement Disorders. 12 (6): 969–972. doi:10.1002/mds.870120620. ISSN   0885-3185. PMID   9399222.
  15. ↑ Louis ED, Dogu O (2009-11-15). "Isolated head tremor: part of the clinical spectrum of essential tremor? Data from population-based and clinic-based case samples". Movement Disorders. 24 (15): 2281–2285. doi:10.1002/mds.22777. ISSN   1531-8257. PMC   2839188 . PMID   19795473.
  16. ↑ Louis ED (September 2001). "Clinical practice. Essential tremor". The New England Journal of Medicine. 345 (12): 887–91. doi:10.1056/nejmcp010928. PMID   11565522.
  17. ↑ Fasano A, Herzog J, Raethjen J, Rose F, Muthuraman M, Volkmann J, et al. (Dec 2010). "Gait ataxia in essential tremor is differentially modulated by thalamic stimulation". Brain. 133 (Pt 12): 3635–3648. doi: 10.1093/brain/awq267 . PMID   20926368.
  18. ↑ Singer C, Sanchez-Ramos J, Weiner WJ (March 1994). "Gait abnormality in essential tremor". Movement Disorders. 9 (2): 193–196. doi:10.1002/mds.870090212. ISSN   0885-3185. PMID   8196682.
  19. ↑ Elble RJ (June 2013). "What is essential tremor?". Curr Neurol Neurosci Rep. 13 (6): 353. doi:10.1007/s11910-013-0353-4. PMC   3674100 . PMID   23591755.
  20. ↑ Ryu DW, Lee SH, Oh YS, An JY, Park JW, Song IU, et al. (2017-05-16). "Clinical Characteristics of Parkinson's Disease Developed from Essential Tremor". Journal of Parkinson's Disease. 7 (2): 369–376. doi:10.3233/JPD-160992. PMID   28409750.
  21. ↑ Biary N, Koller W, Langenberg P (December 1990). "Correlation between essential tremor and migraine headache". Journal of Neurology, Neurosurgery, and Psychiatry. 53 (12): 1060–1062. doi:10.1136/jnnp.53.12.1060. ISSN   0022-3050. PMC   488315 . PMID   2292698.
  22. 1 2 Rajput AH, Rozdilsky B, Ang L, Rajput A (May 1993). "Significance of parkinsonian manifestations in essential tremor". The Canadian Journal of Neurological Sciences. 20 (2): 114–7. doi: 10.1017/s031716710004765x . PMID   8334571. INIST   4838591.
  23. ↑ Benito-León J, Louis ED, Mitchell AJ, Bermejo-Pareja F (2011). "Elderly-onset essential tremor and mild cognitive impairment: a population-based study (NEDICES)". Journal of Alzheimer's Disease. 23 (4): 727–35. doi:10.3233/JAD-2011-101572. PMID   21304183.
  24. ↑ Benito-León J, Louis ED, Bermejo-Pareja F (May 2006). "Elderly-onset essential tremor is associated with dementia". Neurology. 66 (10): 1500–5. doi:10.1212/01.wnl.0000216134.88617.de. PMID   16717208. S2CID   34434554.
  25. ↑ Klein RD, Kincaid RL, Hodgson AS, Harrison JH, Hillers JK, Cronrath JD (October 1987). "Dietary fiber and early weaning on growth and rumen development of calves". Journal of Dairy Science. 70 (10): 2095–104. doi:10.3168/jds.S0022-0302(87)80259-X. PMC   2824583 . PMID   18043006.
  26. ↑ Louis ED (2019). "The Roles of Age and Aging in Essential Tremor: An Epidemiological Perspective". Neuroepidemiology. 52 (1–2): 111–118. doi:10.1159/000492831. PMID   30625472.
  27. 1 2 Cao H, Thompson-Westra J, Hallett M, Haubenberger D (July 2018). "The response of the central and peripheral tremor component to octanoic acid in patients with essential tremor". Clinical Neurophysiology. 129 (7): 1467–1471. doi:10.1016/j.clinph.2018.03.016. PMC   6530908 . PMID   29678370.
  28. ↑ Liang TW, Hurtig H. "Medical management of motor fluctuations and dyskinesia in Parkinson disease". UpToDate.
  29. ↑ Charles PD, Esper GJ, Davis TL, Maciunas RJ, Robertson D (1999-03-15). "Classification of Tremor and Update on Treatment". American Family Physician. 59 (6): 1565–1572. PMID   10193597.
  30. ↑ Bracker MD (December 1994). "A Skin-Deep Diagnosis". The Physician and Sportsmedicine. 22 (12): 79–82. doi:10.1080/00913847.1994.11947721. PMID   29272964.
  31. ↑ Louis ED (2014). ""Essential Tremor" or "the Essential Tremors": Is This One Disease or a Family of Diseases?". Neuroepidemiology. 42 (2): 81–89. doi:10.1159/000356351. ISSN   0251-5350. PMC   3945103 . PMID   24335621.
  32. 1 2 3 4 Ong YL, Deng X, Tan EK (2019-05-01). "Etiologic links between environmental and lifestyle factors and Essential tremor". Annals of Clinical and Translational Neurology. 6 (5): 979–989. doi:10.1002/acn3.758. ISSN   2328-9503. PMC   6529929 . PMID   31139697.
  33. ↑ Louis ED (April 2016). "Essential Tremor: A Common Disorder of Purkinje Neurons?". The Neuroscientist. 22 (2): 108–118. doi:10.1177/1073858415590351. ISSN   1073-8584. PMC   5467972 . PMID   26044399.
  34. ↑ Gironell A, Kulisevsky J, Barbanoj M, López-Villegas D, Hernández G, Pascual-Sedano B (1999-04-01). "A Randomized Placebo-Controlled Comparative Trial of Gabapentin and Propranolol in Essential Tremor". Archives of Neurology. 56 (4): 475–480. doi:10.1001/archneur.56.4.475. ISSN   0003-9942. PMID   10199338.
  35. ↑ Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL (2007-01-15). "A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor". Movement Disorders. 22 (2): 279–282. doi:10.1002/mds.21282. ISSN   0885-3185. PMID   17149715.
  36. 1 2 3 4 5 6 7 Rajput AH, Rajput A (January 2014). "Medical treatment of essential tremor". Journal of Central Nervous System Disease. 6: 29–39. doi:10.4137/JCNSD.S13570. PMC   3999812 . PMID   24812533.
  37. ↑ Deng H, Le W, Jankovic J (June 2007). "Genetics of essential tremor". Brain. 130 (Pt 6): 1456–64. doi: 10.1093/brain/awm018 . PMID   17353225.
  38. ↑ "Essential tremor". Genes and Disease. National Center for Biotechnology Information. 1998.
  39. ↑ "Entry - #190300 - Tremor, Hereditary Essential, 1; ETM1". OMIM.
  40. ↑ Delay C, Tremblay C, Brochu E, Paris-Robidas S, Emond V, Rajput AH, et al. (November 2014). "Increased LINGO1 in the cerebellum of essential tremor patients". Movement Disorders. 29 (13): 1637–47. doi:10.1002/mds.25819. PMID   24531928. S2CID   27331090.
  41. ↑ Kuo SH, Tang G, Louis ED, Ma K, Babji R, Balatbat M, et al. (June 2013). "Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau". Acta Neuropathologica. 125 (6): 879–89. doi:10.1007/s00401-013-1108-7. PMC   3663903 . PMID   23543187.
  42. ↑ Paris-Robidas S, Brochu E, Sintes M, Emond V, Bousquet M, Vandal M, et al. (January 2012). "Defective dentate nucleus GABA receptors in essential tremor". Brain. 135 (Pt 1): 105–16. doi: 10.1093/brain/awr301 . PMID   22120148.
  43. ↑ Vilariño-Güell C, Soto-Ortolaza AI, Rajput A, Mash DC, Papapetropoulos S, Pahwa R, et al. (February 2011). "MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy". Neurology. 76 (7): 670–2. doi:10.1212/WNL.0b013e31820c30c1. PMC   3053340 . PMID   21321341.
  44. ↑ Louis ED (September 2001). "Etiology of essential tremor: should we be searching for environmental causes?". Movement Disorders. 16 (5): 822–9. doi:10.1002/mds.1183. PMID   11746611. S2CID   38809483.
  45. ↑ Dogu O, Louis ED, Tamer L, Unal O, Yilmaz A, Kaleagasi H (November 2007). "Elevated Blood Lead Concentrations in Essential Tremor: A Case–Control Study in Mersin, Turkey". Environmental Health Perspectives. 115 (11): 1564–1568. doi:10.1289/ehp.10352. PMC   2072853 . PMID   18007985.
  46. ↑ "Chronic Lead Exposure: A Non-Traumatic Brain Injury". Brain Injury Association of America. Retrieved 2024-08-02.
  47. ↑ Marambaud P, Dreses-Werringloer U, Vingtdeux V (2009). "Calcium signaling in neurodegeneration". Molecular Neurodegeneration. 4 (1): 20. doi: 10.1186/1750-1326-4-20 . ISSN   1750-1326. PMC   2689218 . PMID   19419557.
  48. ↑ Sanders T, Liu Y, Buchner V, Tchounwou P (January 2009). "Neurotoxic Effects and Biomarkers of Lead Exposure: A Review". Reviews on Environmental Health. 24 (1): 15–45. doi:10.1515/REVEH.2009.24.1.15. ISSN   2191-0308. PMC   2858639 . PMID   19476290.
  49. ↑ Luo J (August 2015). "Effects of Ethanol on the Cerebellum: Advances and Prospects". The Cerebellum. 14 (4): 383–385. doi:10.1007/s12311-015-0674-8. ISSN   1473-4222. PMC   4492805 . PMID   25933648.
  50. ↑ Louis ED, Vonsattel JP (2008-01-30). "The Emerging Neuropathology of Essential Tremor". Movement Disorders. 23 (2): 174–182. doi:10.1002/mds.21731. ISSN   0885-3185. PMC   2692583 . PMID   17999421.
  51. ↑ Louis ED, Vonsattel JP (January 2008). "The emerging neuropathology of essential tremor". Movement Disorders. 23 (2): 174–82. doi:10.1002/mds.21731. PMC   2692583 . PMID   17999421.
  52. ↑ Louis ED (January 2014). "Re-thinking the biology of essential tremor: From models to morphology". Parkinson & Related Disorders. 20 (1): S88-93. doi:10.1016/S1353-8020(13)70023-3. PMID   24262197.
  53. 1 2 Louis ED, Lenka A (13 July 2017). "The Olivary Hypothesis of Essential Tremor: Time to Lay this Model to Rest?". Tremor and Other Hyperkinetic Movements. 7: 473. doi:10.7916/D8FF40RX. PMC   5618117 . PMID   28966877.
  54. 1 2 Mostile G, Jankovic J (October 2010). "Alcohol in essential tremor and other movement disorders". Movement Disorders. 25 (14): 2274–84. doi:10.1002/mds.23240. PMID   20721919. S2CID   39981956.
  55. ↑ Louis ED (October 2009). "Essential tremors: a family of neurodegenerative disorders?". Archives of Neurology. 66 (10): 1202–8. doi:10.1001/archneurol.2009.217. PMC   2762114 . PMID   19822775.
  56. ↑ Louis ED (2014). "'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases?". Neuroepidemiology. 42 (2): 81–9. doi:10.1159/000356351. PMC   3945103 . PMID   24335621.
  57. ↑ Louis ED, Faust PL, Vonsattel JP, Honig LS, Rajput A, Robinson CA, et al. (December 2007). "Neuropathological changes in essential tremor: 33 cases compared with 21 controls". Brain. 130 (Pt 12): 3297–307. doi: 10.1093/brain/awm266 . PMID   18025031.
  58. ↑ Ghika A, Kyrozis A, Potagas C, Louis ED (2015). "Motor and Non-motor Features: Differences between Patients with Isolated Essential Tremor and Patients with Both Essential Tremor and Parkinson's Disease". Tremor and Other Hyperkinetic Movements . 5: 335. doi:10.7916/D83777WK. PMC   4548968 . PMID   26336614.
  59. ↑ Benito-León J, Sanz-Morales E, Melero H, Louis ED, Romero JP, Rocon E, et al. (November 2019). "Graph theory analysis of resting-state functional magnetic resonance imaging in essential tremor". Human Brain Mapping. 40 (16): 4686–4702. doi:10.1002/hbm.24730. PMC   6865733 . PMID   31332912.
  60. ↑ National Toxicology Program (June 2012). NTP monograph on health effects of low-level lead (PDF) (Report). U.S. Department of Health and Human Services. pp. xiii, xv–148. PMID   23964424. S2CID   25344446.
  61. ↑ Kosmowska B, Wardas J (2 December 2021). "The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models". Biomolecules. 11 (12): 1813. doi: 10.3390/biom11121813 . PMC   8698799 . PMID   34944457.
  62. ↑ Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. (January 2018). "Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society". Movement Disorders. 33 (1): 75–87. doi:10.1002/mds.27121. PMC   6530552 . PMID   29193359.
  63. ↑ Louis ED, Dure LS, Pullman S (September 2001). "Essential tremor in childhood: a series of nineteen cases". Movement Disorders. 16 (5): 921–3. doi:10.1002/mds.1182. PMID   11746623. S2CID   30848508.
  64. ↑ Bain PG, Findley LJ, Thompson PD, Gresty MA, Rothwell JC, Harding AE, et al. (August 1994). "A study of hereditary essential tremor". Brain. 117 (4): 805–24. doi:10.1093/brain/117.4.805. PMID   7922467.
  65. ↑ Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED (2003). "Rest tremor in essential tremor patients: Prevalence, clinical correlates, and electrophysiological characteristics". Arch Neurol. 60 (3): 405–410. doi: 10.1001/archneur.60.3.405 . PMID   12633153.
  66. ↑ Rajalingam R, Breen DP, Chen R, Fox S, Kalia LV, Munhoz RP, et al. (2019-08-01). "The clinical significance of lower limb tremors". Parkinsonism & Related Disorders. 65: 165–171. doi:10.1016/j.parkreldis.2019.06.007. hdl: 20.500.11820/fcbc5316-6d53-418f-ba3a-a73208c6f186 . ISSN   1353-8020. PMID   31201091.
  67. ↑ Biary N, Koller W, Langenberg P (December 1990). "Correlation between essential tremor and migraine headache". Journal of Neurology, Neurosurgery, and Psychiatry. 53 (12): 1060–2. doi:10.1136/jnnp.53.12.1060. PMC   488315 . PMID   2292698.
  68. 1 2 3 4 5 6 Hopfner F, Deuschl G (October 2020). "Managing Essential Tremor". Neurotherapeutics. 17 (4): 1603–1621. doi:10.1007/s13311-020-00899-2. PMC   7851235 . PMID   32915385.
  69. 1 2 3 Wagle Shukla A (October 2022). "Diagnosis and Treatment of Essential Tremor". Continuum. 28 (5): 1333–1349. doi:10.1212/CON.0000000000001181. PMID   36222768.
  70. ↑ Ondo WG (May 2020). "Current and Emerging Treatments of Essential Tremor". Neurologic Clinics. 38 (2): 309–323. doi:10.1016/j.ncl.2020.01.002. PMID   32279712.
  71. 1 2 3 Sharma S, Pandey S (2019-10-01). "Treatment of essential tremor: current status". Postgraduate Medical Journal. 96 (1132): 84–93. doi:10.1136/postgradmedj-2019-136647. ISSN   0032-5473. PMID   31575730.
  72. 1 2 3 4 5 Patel MD, Patel M, Jani R, Patel KG, Patel P, Gandhi SK (2024-05-01). "Essential Tremors: A Literature Review of Current Therapeutics". Cureus. 16 (5): e59451. doi: 10.7759/cureus.59451 . ISSN   2168-8184. PMC   11141324 . PMID   38826876.
  73. ↑ Bruno E, Nicoletti A, Quattrocchi G, Allegra R, Filippini G, Colosimo C, et al. (April 2017). "Topiramate for essential tremor". The Cochrane Database of Systematic Reviews. 2017 (4): CD009683. doi:10.1002/14651858.CD009683.pub2. PMC   6478240 . PMID   28409827.
  74. ↑ Bruno E, Nicoletti A, Filippini G, Quattrocchi G, Colosimo C, Zappia M (August 2017). "Zonisamide for essential tremor". The Cochrane Database of Systematic Reviews. 2017 (8): CD009684. doi:10.1002/14651858.CD009684.pub2. PMC   6483684 . PMID   28836659.
  75. ↑ Bruno E, Nicoletti A, Quattrocchi G, Filippini G, Colosimo C, Zappia M (October 2016). "Pregabalin for essential tremor". The Cochrane Database of Systematic Reviews. 10 (7): CD009682. doi:10.1002/14651858.CD009682.pub2. PMC   6461190 . PMID   27763691.
  76. ↑ Anandan C, Jankovic J (2021-01-08). "Botulinum Toxin in Movement Disorders: An Update". Toxins. 13 (1): 42. doi: 10.3390/toxins13010042 . ISSN   2072-6651. PMC   7827923 . PMID   33430071.
  77. ↑ Adler CH, Bansberg SF, Hentz JG, Ramig LO, Buder EH, Witt K, et al. (September 2004). "Botulinum toxin type A for treating voice tremor". Archives of Neurology. 61 (9): 1416–1420. doi:10.1001/archneur.61.9.1416. ISSN   0003-9942. PMID   15364688.
  78. 1 2 Rohani M, Fasano A (2017). "Focused Ultrasound for Essential Tremor: Review of the Evidence and Discussion of Current Hurdles". Tremor and Other Hyperkinetic Movements . 7: 462. doi:10.7916/D8Z89JN1. PMC   5425801 . PMID   28503363.
  79. 1 2 3 4 5 "FDA approves first MRI-guided focused ultrasound device to treat essential tremor" (Press release). FDA. 24 March 2020.
  80. ↑ Aharonson V, Postema M, Gebbie R, Van Der Merwe J, Schlesinger I (2023). "Sobel edge detection for quantifying the effectiveness of focused ultrasound thalamotomy for tremor relief". Current Directions in Biomedical Engineering. 9 (1): 17–20. doi: 10.1515/cdbme-2023-1005 .
  81. ↑ Chang JW, Park CK, Lipsman N, Schwartz ML, Ghanouni P, Henderson JM, et al. (December 2017). "A Prospective Trial of Magnetic Resonance guided Focused Ultrasound Thalamotomy for Essential Tremor: Results at the 2-year Follow-up". Annals of Neurology. 83 (1): 107–114. doi:10.1002/ana.25126. PMID   29265546. S2CID   4437809.
  82. ↑ Hedera P (February 2017). "Emerging strategies in the management of essential tremor". Therapeutic Advances in Neurological Disorders (Review). 10 (2): 137–148. doi:10.1177/1756285616679123. PMC   5367648 . PMID   28382111.
  83. ↑ Singh M, Agrawal M (2020). "Deep Brain Stimulation for Tremor and Dystonia". Neurology India. 68 (8): S187–S195. doi: 10.4103/0028-3886.302472 . ISSN   0028-3886. PMID   33318349.
  84. 1 2 Bain PG, Mally J, Gresty M, Findley LJ (November 1993). "Assessing the impact of essential tremor on upper limb function". Journal of Neurology. 241 (1): 54–61. doi:10.1007/bf00870673. PMID   8138823. S2CID   9502687.
  85. 1 2 Louis ED, Barnes L, Albert SM, Cote L, Schneier FR, Pullman SL, et al. (September 2001). "Correlates of functional disability in essential tremor". Movement Disorders. 16 (5): 914–20. doi:10.1002/mds.1184. PMID   11746622. S2CID   9540572.
  86. ↑ Critchley M (1949). "Observations on essential (heredofamilial) tremor". Brain. 72 (2): 113–139. doi:10.1093/brain/72.2.113. PMID   18136705.
  87. ↑ Busenbark KL, Nash J, Nash S, Hubble JP, Koller WC (1991). "Is essential tremor benign?". Neurology. 41 (12): 1982–1983. doi:10.1212/wnl.41.12.1982. PMID   1745359. S2CID   41199748.
  88. ↑ Louis ED, Ford B, Barnes LF (2000). "Clinical subtypes of essential tremor". Arch Neurol. 57 (8): 1194–1198. doi: 10.1001/archneur.57.8.1194 . PMID   10927801.
  89. 1 2 3 Song P, Zhang Y, Zha M, Yang Q, Ye X, Yi Q, et al. (2021). "The global prevalence of essential tremor, with emphasis on age and sex: A meta-analysis". Journal of Global Health. 11: 04028. doi:10.7189/jogh.11.04028. ISSN   2047-2978. PMC   8035980 . PMID   33880180.
  90. ↑ Louis ED, Ferreira JJ (2010-04-15). "How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor". Movement Disorders. 25 (5): 534–541. doi:10.1002/mds.22838. ISSN   1531-8257. PMID   20175185.
  91. 1 2 Agarwal S, Biagioni MC (2024), "Essential Tremor", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   29763162 , retrieved 2024-07-29
  92. ↑ Benito-León J, Louis ED (December 2006). "Essential tremor: emerging views of a common disorder". Nature Clinical Practice. Neurology. 2 (12): 666–678, quiz 2p following 691. doi:10.1038/ncpneuro0347. ISSN   1745-834X. PMID   17117170.
  93. ↑ Healy, David (director) (January 18, 1993). Katharine Hepburn: All About Me. Turner Home Entertainment.
  94. ↑ Claiborne RC (July 22, 2003). "Q & A; Head and Hand Tremors". The New York Times. Retrieved November 3, 2013.
  95. 1 2 Berg AS (2004) [2003]. Kate Remembered: Katharine Hepburn, a personal biography. London: Pocket. p. 260. ISBN   978-0-7434-1563-7.
  96. ↑ Conova S (January 29, 2003). "Stopping essential tremor". In Vivo. 2 (2). Columbia University Health Sciences. Archived from the original on February 16, 2017. Retrieved November 3, 2013.
  97. ↑ Dickens H (1990) [1971]. The Films of Katharine Hepburn . New York City, NY: Carol Publishing Group. p.  31. ISBN   978-0-8065-1175-7.
  98. ↑ Grow K (2019-01-03). "Daryl Dragon, Captain and Tennille's Captain, Dead at 76". Rolling Stone. Retrieved 2022-03-02.
  99. ↑ Goodyear D (14 March 2011). "Hollywood Shadows". The New Yorker. Retrieved 2018-12-13.
  100. ↑ "Downton Abbey creator reveals reason he gave Mr Carson a tremor". Breaking News.ie. November 19, 2019. Archived from the original on December 17, 2019. Retrieved August 20, 2020.
  101. ↑ "Essential Tremor". Matthewcaws.com. Retrieved April 9, 2022.
  102. 1 2 Miwa H (2007). "Rodent models of tremor". Cerebellum. 6 (1): 66–72. doi:10.1080/14734220601016080. PMID   17366267. S2CID   24179439.
  103. ↑ Kuhn W, Müller T, Grosse H, Rommelspacher H (1996). "Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients". Journal of Neural Transmission. 103 (12): 1435–40. doi:10.1007/bf01271257. PMID   9029410. S2CID   21230301.
  104. ↑ Pfau W, Skog K (March 2004). "Exposure to beta-carbolines norharman and harman". Journal of Chromatography B. 802 (1): 115–26. doi: 10.1016/j.jchromb.2003.10.044 . PMID   15036003.
  105. ↑ Louis ED, Pellegrino KM, Factor-Litvak P, Rios E, Jiang W, Henchcliffe C, et al. (September 2008). "Cancer and blood concentrations of the comutagen harmane in essential tremor". Movement Disorders. 23 (12): 1747–51. doi:10.1002/mds.22084. PMC   2597456 . PMID   18709680.
  106. ↑ Louis ED, Factor-Litvak P, Gerbin M, Slavkovich V, Graziano JH, Jiang W, et al. (March 2011). "Blood harmane, blood lead, and severity of hand tremor: evidence of additive effects". Neurotoxicology. 32 (2): 227–32. Bibcode:2011NeuTx..32..227L. doi:10.1016/j.neuro.2010.12.002. PMC   3073713 . PMID   21145352.
  107. ↑ Louis ED, Jiang W, Gerbin M, Viner AS, Factor-Litvak P, Zheng W (2012). "Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York". Journal of Toxicology and Environmental Health. Part A. 75 (12): 673–83. Bibcode:2012JTEHA..75..673L. doi:10.1080/15287394.2012.688485. PMC   3412610 . PMID   22757671.
  108. ↑ Louis ED, Zheng W, Jiang W, Bogen KT, Keating GA (June 2007). "Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness". Journal of Toxicology and Environmental Health. Part A. 70 (12): 1014–9. Bibcode:2007JTEHA..70.1014L. doi:10.1080/15287390601172015. PMC   4993204 . PMID   17497412.
  109. ↑ Louis ED, Keating GA, Bogen KT, Rios E, Pellegrino KM, Factor-Litvak P (2008). "Dietary epidemiology of essential tremor: meat consumption and meat cooking practices". Neuroepidemiology. 30 (3): 161–6. doi:10.1159/000122333. PMC   2821442 . PMID   18382115.
  110. ↑ Louis ED, Zheng W, Applegate L, Shi L, Factor-Litvak P (August 2005). "Blood harmane concentrations and dietary protein consumption in essential tremor". Neurology. 65 (3): 391–6. doi:10.1212/01.wnl.0000172352.88359.2d. PMC   4993192 . PMID   16087903.
  111. ↑ Haubenberger D, McCrossin G, Lungu C, Considine E, Toro C, Nahab FB, et al. (March 2013). "Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study". Neurology. 80 (10): 933–40. doi:10.1212/WNL.0b013e3182840c4f. PMC   3653213 . PMID   23408867.
  112. ↑ Voller B, Lines E, McCrossin G, Tinaz S, Lungu C, Grimes G, et al. (April 2016). "Dose-escalation study of octanoic acid in patients with essential tremor". The Journal of Clinical Investigation. 126 (4): 1451–7. doi:10.1172/JCI83621. PMC   4811161 . PMID   26927672.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.